Advisortrust Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.74M Buy
1,502
+29
+2% +$34.2K 0.55% 41
2026
Q2
$1.77M Buy
1,473
+93
+7% +$95K 0.6% 37
2026
Q1
$1.27M Sell
1,380
-8
-0.6% -$8.11K 0.53% 36
2025
Q4
$1.49M Buy
+1,388
New +$1.33M 0.66% 29

Other funds holding LLY

Advisortrust Partners's LLY Position: Q3 2026 in Review

Advisortrust Partners increased its Eli Lilly (LLY) stake by 2% in Q3 2026, buying an estimated $34.2K and bringing the position to 1,502 shares worth $1.74M. The position accounts for 0.55% of the portfolio, ranked #41.

Advisortrust Partners first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.77M in Q2 2026. 4,625 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Advisortrust Partners held 1,502 shares of Eli Lilly worth $1.74M as of Q3 2026.
  • Advisortrust Partners bought 29 Eli Lilly shares in Q3 2026, an estimated $34.2K.
  • Eli Lilly made up 0.55% of Advisortrust Partners's portfolio in Q3 2026, its #41 holding.
  • Advisortrust Partners first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • Advisortrust Partners's Eli Lilly position peaked at $1.77M in Q2 2026.
  • 4,625 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Advisortrust Partners's 13F filing for Q3 2026, filed 2 Nov 2026.